Drug Trial Radar · NCT06482177
The COAT Trial: Cequa's Onset of Action Trial
Last checked: Nov 20, 2026Latest source record: Jul 1, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
52
Actual
Start
Oct 12, 2023
Primary completion
Jun 5, 2024
Study completion Jun 5, 2024
Sponsor
- Lead sponsor
- Research Insight LLCIndustry
- Sponsor type
- Industry
- First posted
- Jul 1, 2024
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Cequa's Onset of Action Trial: an Investigation of CEQUA's Speed of Onset in Improving Ocular Surface Health in Dry Eye Patients
Conditions
- Dry Eye
Interventions
Cyclosporine ophthalmic solutionDrug
Cyclosporine BID in the study eye
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in corneal high order aberrations (HOA)Time frame: After 7, 14, and 28 days of treatment
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Harvard Eye Associates
Laguna Hills, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.